Reconstruction of Tissue-Specific Metabolic Networks Using CORDA

Human metabolism involves thousands of reactions and metabolites. To interpret this complexity, computational modeling becomes an essential experimental tool. One of the most popular techniques to study human metabolism as a whole is genome scale modeling. A key challenge to applying genome scale modeling is identifying critical metabolic reactions across diverse human tissues. Here we introduce a novel algorithm called Cost Optimization Reaction Dependency Assessment (CORDA) to build genome scale models in a tissue-specific manner. CORDA performs more efficiently computationally, shows better agreement to experimental data, and displays better model functionality and capacity when compared to previous algorithms. CORDA also returns reaction associations that can greatly assist in any manual curation to be performed following the automated reconstruction process. Using CORDA, we developed a library of 76 healthy and 20 cancer tissue-specific reconstructions. These reconstructions identified which metabolic pathways are shared across diverse human tissues. Moreover, we identified changes in reactions and pathways that are differentially included and present different capacity profiles in cancer compared to healthy tissues, including up-regulation of folate metabolism, the down-regulation of thiamine metabolism, and tight regulation of oxidative phosphorylation.

[1]  K. Kothapalli,et al.  FADS2 Function Loss at the Cancer Hotspot 11q13 Locus Diverts Lipid Signaling Precursor Synthesis to Unusual Eicosanoid Fatty Acids , 2011, PloS one.

[2]  Min Kyung Kim,et al.  Methods for integration of transcriptomic data in genome-scale metabolic models , 2014, Computational and structural biotechnology journal.

[3]  Anastasia K Yocum,et al.  The role of sarcosine metabolism in prostate cancer progression. , 2013, Neoplasia.

[4]  Jie Zheng,et al.  Energy metabolism of cancer: Glycolysis versus oxidative phosphorylation (Review). , 2012, Oncology letters.

[5]  S. Prescott,et al.  Fatty acid CoA ligase 4 is up-regulated in colon adenocarcinoma. , 2001, Cancer research.

[6]  Andrea Viale,et al.  Tumors and mitochondrial respiration: a neglected connection. , 2015, Cancer research.

[7]  Christian Frezza,et al.  Defects in mitochondrial metabolism and cancer , 2014, Cancer & metabolism.

[8]  D. Horsfall,et al.  Elevated levels of versican but not decorin predict disease progression in early-stage prostate cancer. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[9]  Monica L. Mo,et al.  Global reconstruction of the human metabolic network based on genomic and bibliomic data , 2007, Proceedings of the National Academy of Sciences.

[10]  E. Baudin,et al.  Tyrosine kinase inhibitor treatments in patients with metastatic thyroid carcinomas: a retrospective study of the TUTHYREF network. , 2014, European journal of endocrinology.

[11]  Dragana Nikitovic,et al.  Glycosaminoglycans: key players in cancer cell biology and treatment , 2012, The FEBS journal.

[12]  B. Palsson,et al.  Large-scale in silico modeling of metabolic interactions between cell types in the human brain , 2010, Nature Biotechnology.

[13]  Zoran Nikoloski,et al.  Generalized framework for context-specific metabolic model extraction methods , 2014, Front. Plant Sci..

[14]  Natapol Pornputtapong,et al.  Reconstruction of Genome-Scale Active Metabolic Networks for 69 Human Cell Types and 16 Cancer Types Using INIT , 2012, PLoS Comput. Biol..

[15]  M Cascante,et al.  The effect of thiamine supplementation on tumour proliferation. A metabolic control analysis study. , 2001, European journal of biochemistry.

[16]  Chao Sun,et al.  Anti-cancer activity of glucosamine through inhibition of N-linked glycosylation , 2014, Cancer Cell International.

[17]  E. Lundberg,et al.  Towards a knowledge-based Human Protein Atlas , 2010, Nature Biotechnology.

[18]  Z. Nikoloski,et al.  Context-Specific Metabolic Model Extraction Based on Regularized Least Squares Optimization , 2015, PloS one.

[19]  C. Gille,et al.  HepatoNet1: a comprehensive metabolic reconstruction of the human hepatocyte for the analysis of liver physiology , 2010, Molecular systems biology.

[20]  T. Mak,et al.  Regulation of cancer cell metabolism , 2011, Nature Reviews Cancer.

[21]  Lan Thi Hoàng Nguyễn,et al.  The role of thiamine in cancer: possible genetic and cellular signaling mechanisms. , 2013, Cancer genomics & proteomics.

[22]  Amanda E Toland,et al.  Salivary gland cancer in BRCA-positive families: a retrospective review. , 2014, JAMA otolaryngology-- head & neck surgery.

[23]  F. Claessens,et al.  Squalene Synthase, a Determinant of Raft-associated Cholesterol and Modulator of Cancer Cell Proliferation* , 2007, Journal of Biological Chemistry.

[24]  E J Thonar,et al.  Keratan sulfate levels in sera of patients bearing cartilage tumors , 1987, Cancer.

[25]  M. Bartlett,et al.  Up-regulation of vitamin B1 homeostasis genes in breast cancer. , 2013, The Journal of nutritional biochemistry.

[26]  Bernhard O. Palsson,et al.  A detailed genome-wide reconstruction of mouse metabolism based on human Recon 1 , 2010, BMC Systems Biology.

[27]  Lihong Ye,et al.  MiR-205 modulates abnormal lipid metabolism of hepatoma cells via targeting acyl-CoA synthetase long-chain family member 1 (ACSL1) mRNA. , 2014, Biochemical and biophysical research communications.

[28]  Robert L. Smith,et al.  Direction Choice for Accelerated Convergence in Hit-and-Run Sampling , 1998, Oper. Res..

[29]  H. J. Greenberg,et al.  Monte Carlo sampling can be used to determine the size and shape of the steady-state flux space. , 2004, Journal of theoretical biology.

[30]  R. Moreno-Sánchez,et al.  Bioenergetic pathways in tumor mitochondria as targets for cancer therapy and the importance of the ROS-induced apoptotic trigger. , 2010, Molecular aspects of medicine.

[31]  Maria Paola Costi,et al.  Novel approaches for targeting thymidylate synthase to overcome the resistance and toxicity of anticancer drugs. , 2010, Journal of medicinal chemistry.

[32]  Huaqing Zhao,et al.  The H+-Linked Monocarboxylate Transporter (MCT1/SLC16A1): A Potential Therapeutic Target for High-Risk Neuroblastoma , 2006, Molecular Pharmacology.

[33]  Seongwon Seo,et al.  BMC Systems Biology BioMed Central Methodology article , 2009 .

[34]  Mathias Uhlen,et al.  Identifying anti-growth factors for human cancer cell lines through genome-scale metabolic modeling , 2015, Scientific Reports.

[35]  Claude Chelala,et al.  Genome-Wide Analysis of Pancreatic Cancer Using Microarray-Based Techniques , 2008, Pancreatology.

[36]  P. Bougnoux,et al.  n-3 polyunsaturated fatty acids and cancer. , 1999, Current opinion in clinical nutrition and metabolic care.

[37]  A. Mittelman,et al.  Adenosine deaminase activity in patients with renal adenocarcinoma , 1977, Cancer.

[38]  Z N Oltvai,et al.  Contribution of serine, folate and glycine metabolism to the ATP, NADPH and purine requirements of cancer cells , 2013, Cell Death and Disease.

[39]  Sun-Hwa Park,et al.  Alcohol induces cell proliferation via hypermethylation of ADHFE1 in colorectal cancer cells , 2014, BMC Cancer.

[40]  E. Ruppin,et al.  Predicting metabolic biomarkers of human inborn errors of metabolism , 2009, Molecular systems biology.

[41]  I. Nookaew,et al.  Integration of clinical data with a genome-scale metabolic model of the human adipocyte , 2013, Molecular systems biology.

[42]  Aarash Bordbar,et al.  A multi-tissue type genome-scale metabolic network for analysis of whole-body systems physiology , 2011, BMC Systems Biology.

[43]  Emma Saavedra,et al.  Energy metabolism in tumor cells , 2007, The FEBS journal.

[44]  C. Maranas,et al.  Recent advances in the reconstruction of metabolic models and integration of omics data. , 2014, Current opinion in biotechnology.

[45]  Jianxin Xie,et al.  A role for the mitochondrial pyruvate carrier as a repressor of the Warburg effect and colon cancer cell growth. , 2014, Molecular cell.

[46]  Yang Liu,et al.  Increased MTHFD2 expression is associated with poor prognosis in breast cancer , 2014, Tumor Biology.

[47]  R. Mahadevan,et al.  The effects of alternate optimal solutions in constraint-based genome-scale metabolic models. , 2003, Metabolic engineering.

[48]  P. Skehan,et al.  Membrane-active drugs potentiate the killing of tumor cells by D-glucosamine. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[49]  Jason A. Papin,et al.  Applications of genome-scale metabolic reconstructions , 2009, Molecular systems biology.

[50]  B. Jang,et al.  D-glucosamine inhibits proliferation of human cancer cells through inhibition of p70S6K. , 2007, Biochemical and biophysical research communications.

[51]  Intawat Nookaew,et al.  Proteome- and transcriptome-driven reconstruction of the human myocyte metabolic network and its use for identification of markers for diabetes. , 2015, Cell reports.

[52]  Bernhard O. Palsson,et al.  Context-Specific Metabolic Networks Are Consistent with Experiments , 2008, PLoS Comput. Biol..

[53]  A. Theocharis,et al.  The biological role of chondroitin sulfate in cancer and chondroitin-based anticancer agents. , 2008, In vivo.

[54]  Wei Huang,et al.  Validation and target gene screening of hsa‐miR‐205 in lung squamous cell carcinoma , 2014, Chinese medical journal.

[55]  Jens Nielsen,et al.  Flux balance analysis predicts essential genes in clear cell renal cell carcinoma metabolism , 2015, Scientific Reports.

[56]  D F Horrobin,et al.  Differential killing of human carcinoma cells supplemented with n-3 and n-6 polyunsaturated fatty acids. , 1986, Journal of the National Cancer Institute.

[57]  B. Palsson,et al.  Constraining the metabolic genotype–phenotype relationship using a phylogeny of in silico methods , 2012, Nature Reviews Microbiology.

[58]  D F Horrobin,et al.  Selective killing of human cancer cells by polyunsaturated fatty acids. , 1985, Prostaglandins, leukotrienes, and medicine.

[59]  Nathan E. Lewis,et al.  The evolution of genome-scale models of cancer metabolism , 2013, Front. Physiol..

[60]  Robert V Farese,et al.  Cellular fatty acid metabolism and cancer. , 2013, Cell metabolism.

[61]  Eero Pukkala,et al.  Cancer risk after renal transplantation in the nordic countries, 1964–1986 , 1995, International journal of cancer.

[62]  Ines Thiele,et al.  Predicting the impact of diet and enzymopathies on human small intestinal epithelial cells , 2013, Human molecular genetics.

[63]  Dmitri D. Pervouchine,et al.  The human transcriptome across tissues and individuals , 2015, Science.

[64]  A Senra Varela,et al.  Serum ceruloplasmin as a diagnostic marker of cancer. , 1997, Cancer letters.

[65]  S. Lakhani,et al.  Salivary gland-like tumours of the breast: surgical and molecular pathology , 2003, Journal of clinical pathology.

[66]  Gabriela Kalna,et al.  Haem oxygenase is synthetically lethal with the tumour suppressor fumarate hydratase , 2011, Nature.

[67]  G. von Heijne,et al.  Tissue-based map of the human proteome , 2015, Science.

[68]  I. Amelio,et al.  Serine and glycine metabolism in cancer☆ , 2014, Trends in biochemical sciences.

[69]  Elina Hyppönen,et al.  Vitamin D and adipose tissue—more than storage , 2014, Front. Physiol..

[70]  I. Nookaew,et al.  Chromosome 3p loss of heterozygosity is associated with a unique metabolic network in clear cell renal carcinoma , 2014, Proceedings of the National Academy of Sciences.

[71]  J. Dickerson,et al.  The thiamin status of early cancer patients with particular reference to those with breast and bronchial carcinomas. , 1976, Oncology.

[72]  D. Horsfall,et al.  Elevated levels of peritumoral chondroitin sulfate are predictive of poor prognosis in patients treated by radical prostatectomy for early-stage prostate cancer. , 1999, Cancer research.

[73]  Yoshihiro Fujita,et al.  Alteration of adenosine deaminase levels in peripheral blood lymphocytes of patients with gastric cancer , 1985, The Japanese journal of surgery.

[74]  M. Guppy,et al.  Cancer metabolism: facts, fantasy, and fiction. , 2004, Biochemical and biophysical research communications.

[75]  R. Johnson,et al.  Decreased lymphocyte adenosine deaminase activity in tumor patients. , 1976, Cancer research.

[76]  Zachary A. King,et al.  Constraint-based models predict metabolic and associated cellular functions , 2014, Nature Reviews Genetics.

[77]  R. Sutherland,et al.  Molecular markers of prostate cancer outcome. , 2005, European journal of cancer.

[78]  Nikos Vlassis,et al.  Fast Reconstruction of Compact Context-Specific Metabolic Network Models , 2013, PLoS Comput. Biol..

[79]  H Matsui,et al.  Role of squalene synthase in prostate cancer risk and the biological aggressiveness of human prostate cancer , 2012, Prostate Cancer and Prostatic Diseases.

[80]  Philip E. Bourne,et al.  Drug Off-Target Effects Predicted Using Structural Analysis in the Context of a Metabolic Network Model , 2010, PLoS Comput. Biol..

[81]  Ronan M. T. Fleming,et al.  A community-driven global reconstruction of human metabolism , 2013, Nature Biotechnology.

[82]  Markus J. Herrgård,et al.  Network-based prediction of human tissue-specific metabolism , 2008, Nature Biotechnology.

[83]  Jeffrey D Orth,et al.  What is flux balance analysis? , 2010, Nature Biotechnology.

[84]  Dong Kyung Chang,et al.  Alcohol dehydrogenase, iron containing, 1 promoter hypermethylation associated with colorectal cancer differentiation , 2013, BMC Cancer.

[85]  B. Palsson,et al.  Uniform sampling of steady-state flux spaces: means to design experiments and to interpret enzymopathies. , 2004, Biophysical journal.

[86]  E. Ruppin,et al.  Computational reconstruction of tissue-specific metabolic models: application to human liver metabolism , 2010, Molecular systems biology.

[87]  Bernhard O. Palsson,et al.  GIM3E: condition-specific models of cellular metabolism developed from metabolomics and expression data , 2013, Bioinform..

[88]  Bernhard O. Palsson,et al.  The human metabolic reconstruction Recon 1 directs hypotheses of novel human metabolic functions , 2011, BMC Systems Biology.

[89]  E. Gottlieb,et al.  Targeting metabolic transformation for cancer therapy , 2010, Nature Reviews Cancer.

[90]  Peng Huang,et al.  Superoxide dismutase as a target for the selective killing of cancer cells , 2000, Nature.

[91]  T. Tsuruo,et al.  De novo fatty-acid synthesis and related pathways as molecular targets for cancer therapy , 2009, British Journal of Cancer.

[92]  George W. Yip,et al.  Therapeutic value of glycosaminoglycans in cancer , 2006, Molecular Cancer Therapeutics.

[93]  N. Wall,et al.  Antimetabolite Treatment for Pancreatic Cancer , 2014, Chemotherapy.

[94]  Jason A. Papin,et al.  Integration of expression data in genome-scale metabolic network reconstructions , 2012, Front. Physio..

[95]  Jung Hun Song,et al.  An orally administered multitarget tyrosine kinase inhibitor, SU11248, is a novel potent inhibitor of thyroid oncogenic RET/papillary thyroid cancer kinases. , 2006, The Journal of clinical endocrinology and metabolism.

[96]  K. Hemminki,et al.  Skin cancer and non-Hodgkin's lymphoma as second malignancies. markers of impaired immune function? , 2003, European journal of cancer.

[97]  D. Horsfall,et al.  Elevated stromal chondroitin sulfate glycosaminoglycan predicts progression in early-stage prostate cancer. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[98]  T. Cotter,et al.  DUOX enzyme activity promotes AKT signalling in prostate cancer cells. , 2012, Anticancer research.

[99]  J. Nielsen,et al.  Identification of anticancer drugs for hepatocellular carcinoma through personalized genome‐scale metabolic modeling , 2014, Molecular systems biology.

[100]  V. Mootha,et al.  Metabolic enzyme expression highlights a key role for MTHFD2 and the mitochondrial folate pathway in cancer , 2014, Nature Communications.

[101]  M. Uhlén,et al.  Genome-scale metabolic modelling of hepatocytes reveals serine deficiency in patients with non-alcoholic fatty liver disease , 2014, Nature Communications.

[102]  Jae Yong Ryu,et al.  Reconstruction of genome-scale human metabolic models using omics data. , 2015, Integrative biology : quantitative biosciences from nano to macro.

[103]  Ronan M. T. Fleming,et al.  Quantitative prediction of cellular metabolism with constraint-based models: the COBRA Toolbox v2.0 , 2007, Nature Protocols.

[104]  Nathan E Lewis,et al.  Analysis of omics data with genome-scale models of metabolism. , 2013, Molecular bioSystems.

[105]  J. H. Quastel,et al.  Inhibition of Tumour Growth by D-Glucosamine , 1953, Nature.

[106]  A. Bordbar,et al.  Using the reconstructed genome‐scale human metabolic network to study physiology and pathology , 2012, Journal of internal medicine.

[107]  Natapol Pornputtapong,et al.  Human metabolic atlas: an online resource for human metabolism , 2015, Database J. Biol. Databases Curation.

[108]  Nathan D. Price,et al.  Reconstruction of genome-scale metabolic models for 126 human tissues using mCADRE , 2012, BMC Systems Biology.

[109]  Judy Yan,et al.  PKM2 contributes to cancer metabolism. , 2015, Cancer letters.

[110]  Dan Gao,et al.  Vitamin D signalling in adipose tissue , 2012, British Journal of Nutrition.

[111]  Charles DeLisi,et al.  Pathway-based classification of cancer subtypes , 2012, Biology Direct.

[112]  J. Bertino,et al.  Cancer research: from folate antagonism to molecular targets. , 2009, Best practice & research. Clinical haematology.

[113]  Xianglin Shi,et al.  Sustained JNK1 activation is associated with altered histone H3 methylations in human liver cancer. , 2009, Journal of hepatology.

[114]  Nathan E. Lewis,et al.  Multi-Tissue Computational Modeling Analyzes Pathophysiology of Type 2 Diabetes in MKR Mice , 2014, PloS one.

[115]  G. Kloss,et al.  Accumulation of radioiodinated tyrosine derivatives in the adrenal medulla and in melanomas , 1979, European Journal of Nuclear Medicine.

[116]  John T. Wei,et al.  Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression , 2009, Nature.

[117]  Kristiina Iljin,et al.  High-throughput RNAi screening for novel modulators of vimentin expression identifies MTHFD2 as a regulator of breast cancer cell migration and invasion , 2012, Oncotarget.

[118]  M. Mańczak,et al.  Oxidase activity of ceruloplasmin and concentrations of copper and zinc in serum of cancer patients. , 2001, Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements.

[119]  B. Palsson,et al.  Candidate Metabolic Network States in Human Mitochondria , 2005, Journal of Biological Chemistry.

[120]  Debashis Ghosh,et al.  Erratum: Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression (Nature (2009) 457 (910-914) DOI: 10.1038/nature07762) , 2013 .

[121]  S. Kaye,et al.  New antimetabolites in cancer chemotherapy and their clinical impact. , 1998, British Journal of Cancer.

[122]  B. Palsson,et al.  Insight into human alveolar macrophage and M. tuberculosis interactions via metabolic reconstructions , 2010, Molecular systems biology.

[123]  L. Cantley,et al.  Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.

[124]  Salvatore Piscuoglio,et al.  Are acinic cell carcinomas of the breast and salivary glands distinct diseases? , 2015, Histopathology.

[125]  Brooke L. Fridley,et al.  Gene set analysis of purine and pyrimidine antimetabolites cancer therapies , 2011, Pharmacogenetics and genomics.

[126]  M. Krajinovic,et al.  Dihydrofolate Reductase Gene Variations in Susceptibility to Disease and Treatment Outcomes , 2010, Current genomics.

[127]  S. Morris Regulation of enzymes of the urea cycle and arginine metabolism. , 2002, Annual review of nutrition.

[128]  S. Lee,et al.  Integrative genome-scale metabolic analysis of Vibrio vulnificus for drug targeting and discovery , 2011, Molecular systems biology.